Video Experimental Relacionado
Updated: Aug 9, 2026
11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
Respuesta a la dosis en el tratamiento del cáncer de mama
T H Stewart1, M W Retsky, S C Tsai
1Ottawa General Hospital, Ontario, Canada.
Lancet (London, England)
|February 12, 1994
Resumen
Los fármacos eficaces contra el cáncer de mama reducen las citoquinas del sistema inmunológico de una manera dependiente de la dosis. Esta reducción de citoquinas puede contribuir a la remisión completa en pacientes con cáncer de mama metastásico.
Área de la Ciencia:
- Oncología Oncología.
- Inmunología Inmunología.
Sus antecedentes:
- El tratamiento del cáncer de mama metastásico sigue siendo un desafío significativo.
- El papel del sistema inmunológico en la regresión del cáncer es complejo.
Objetivo del estudio:
- Para investigar la relación entre la dosis del fármaco, la regresión del cáncer y la producción de citoquinas del sistema inmunológico.
- Explorar el mecanismo potencial que vincula la eficacia del fármaco a la remisión completa.
Principales métodos:
- Análisis de la eficacia del fármaco para causar la regresión del cáncer de mama metastásico.
- Cuantificación de los niveles de citoquinas producidas por el sistema inmunológico en respuesta al tratamiento.
Principales resultados:
- Los fármacos eficaces en la regresión del cáncer de mama metastásico demostraron una reducción dosis-dependiente en la producción de citoquinas.
- Se observó una correlación entre el grado de reducción de citoquinas y la dosis del fármaco.
Conclusiones:
- La reducción inducida por fármacos de las citoquinas del sistema inmunológico es un factor potencial para lograr una remisión completa.
- Este hallazgo puede informar futuras estrategias terapéuticas para el cáncer de mama metastásico.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...